The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...

There remains a need for organizations and stakeholders to develop guidance for prescribing ketamine as a pain treatment.

An overview of the topics to be most important published in the past year, at the 2025 annual meeting of the Society for Ambulatory Anesthesia.